During the past decade, CH conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 4 trials, followed by "GERCOR - Multidisciplinary Oncology Cooperative Group" with 4 trials sponsored, "Acute Leukemia French Association" with 3 trials sponsored, "Centre Hospitalier Intercommunal Creteil" with 2 trials sponsored and "Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH" #1 collaborator was "Groupe Francais De Pneumo-Cancerologie" with 2 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "CHU Nantes" with 1 trials as a collaborator and "Cancer Research UK" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "CH" are "Breast Cancer" (4 trials), "Acute Myeloid Leukemia" (3 trials), "Colorectal Cancer" (2 trials), "Critical Care" (2 trials) and "Intensive Care Unit Syndrome" (2 trials). Many other conditions were trialed in "CH" in a lesser frequency.

Most popular intervention types in "CH" are "Drug" (18 trials), "Other" (6 trials), "Biological" (3 trials), "Radiation" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "bevacizumab" (2 trials), "fluorouracil" (2 trials), "gemcitabine hydrochloride" (2 trials), "radiation therapy" (2 trials) and "5-FU/LV" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH" are 25 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "CH". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in CH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CH, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

CH has several departments that took part in Clinical trials: "Service de Pneumologie" - 2 trials